Intas Pharmaceuticals, a company based in India, has launched RAZUMAB™, an anti-VEGF drug that is “biosimilar” to Lucentis. This means that RAZUMAB has a synthesized chemical structure that can substitute for, but not duplicate, Lucentis. To make biosimilarity possible, scientists must show that the new product is highly similar and have no significant differences from [Read More]
News
New Device Helps Blind People See With Their Tongues
The Food and Drug Administration has announced marketing approval of a new device that can help orient people who are blind by helping them process visual images with their tongues. The BrainPort is a battery-powered device that includes a video camera mounted on a pair of glasses and a small, flat intra-oral device containing a [Read More]
Summary of Research and Development – 2015
by Dan Roberts (Also available in audiovisual format) INTRODUCTION This is my 10th annual summary of leading research and developments that have occurred during the past 12 months in the field of blindness and low vision. For more details about any of the reports, sources are provided. Many studies and clinical trials are moving ever [Read More]
L-DOPA May Slow Development of AMD
The color (pigmentation) of the retina, or lack thereof, is thought to play a role in the development of age-related macular degeneration (AMD). The substance that provides pigmentation is melanin, and a precursor to the pigment melanin is called L-DOPA. Since L-DOPA converts into dopamine in the brain, it has been used as a treatment [Read More]
Learn About Comprehensive Dilated Eye Exams
People of all ages should have their eyesight tested to keep their vision at its best. Children usually have vision screening in school or at their pediatrician’s office. Adults, however, may require more than vision screening. Even if your vision seems fine, the only way to know for sure that your eyes are healthy is [Read More]